Table 3.
Overall Survival of Glioma Patients by Univariate Analysis
| Variables | Patients | Overall Survival Time (Months) | P value | |
|---|---|---|---|---|
| (n, %) | Mean ± SD | 3-Year OS | ||
| Sex | 0.520 | |||
| Female | 42 (39.3%) | 42.6 ± 3.4 | 59.5% | |
| Male | 65 (60.7%) | 35.8 ± 3.1 | 48.5% | |
| Age (Years) | 0.668 | |||
| ≤50 | 50 (46.7%) | 36.8 ± 3.5 | 45.8% | |
| >50 | 57 (53.3%) | 39.8 ± 3.1 | 51.6% | |
| Tumor Size | 0.003** | |||
| ≤5 cm | 64 (59.8%) | 44.5 ± 2.9 | 60.4% | |
| >5 cm | 43 (40.2%) | 29.3 ± 3.4 | 31.3% | |
| WHO Grade | <0.001*** | |||
| II | 21 (19.6%) | 60.7 ± 3.3 | 90.5% | |
| III | 34 (31.8%) | 41.4 ± 4.0 | 54.3% | |
| IV | 52 (48.6%) | 27.4 ± 2.8 | 28.2% | |
| KPS Score | 0.760 | |||
| ≤90 | 65 (60.7%) | 39.2 ± 2.9 | 47.8% | |
| >90 | 42 (39.3%) | 37.3 ± 3.9 | 50.0% | |
| Resection Pattern | 0.035* | |||
| GTR | 84 (78.5%) | 40.8 ± 2.5 | 53.2% | |
| STR | 23 (21.5%) | 29.4 ± 5.0 | 33.0% | |
| SCAMP3 Expression | <0.001*** | |||
| Low | 63 (58.9%) | 48.0 ± 2.8 | 71.0% | |
| High | 44 (41.1%) | 24.7 ± 2.9 | 17.0% | |
Notes: *P<0.05, **P<0.01, ***P<0.001 by Log-rank test.